In this issue:
Care pathways for people with early-stage T1D in Australia
Exogenous opioids and the human endocrine system
Advanced thyroid cancer: Definitions and management
Understanding, diagnosing and treating FH
Fezolinetant for moderate to severe vasomotor symptoms associated with menopause
PBS changes: November 2024
Changes to the regulation of compounding GLP-1 RA products
Counterfeit Ozempic pens detected and adverse event reported
Updates to medication chart legislation
New Australian diabetes clinical trials network
ATA 2024 Annual Meeting Abstracts available online
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)